University Hospital of Child and Adolescent Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.
Department of Child and Adolescent Psychiatry, Center for Psychosocial Medicine, University of Heidelberg, Heidelberg, Germany.
Eur Child Adolesc Psychiatry. 2023 Apr;32(4):685-695. doi: 10.1007/s00787-021-01919-y. Epub 2021 Dec 1.
Home treatment (HT) may offer an effective and cost-efficient alternative to inpatient treatment for children and adolescents with acute mental disorders. This study introduces and evaluates a pilot HT project from Bern, Switzerland, with HT completely replacing an inpatient treatment. A total of n = 133 children and adolescents with acute mental disorders and inpatient treatment needs were treated either in the new HT program (n = 37) or in an active control group with inpatient treatment as usual (I-TAU, n = 96). Psychopathological burden was assessed by the Health of the Nation Outcome Scale for Children and Adolescents clinician-rated (HoNOSCA) and self-rated (HoNOSCA-SR) at the time of admission and at discharge. Treatment effects were assessed and compared using Augmented Inverse Probability Weights to adjust for baseline differences and to control for treatment duration. Participants ranged in age from 6 to 17 years (M = 13.71 years, SD = 2.93), 54% were female. HT resulted in significant improvements in the HoNOSCA (d = 0.79, p < .001) and HoNOSCA-SR (d = 0.63, p = .006). No significant differences on treatment effects were observed between HT and the reference group I-TAU in the HoNOSCA (d = 0.01, p = .96) or the HoNOSCA-SR (d = 0.11, p = .63). Overall, results indicate HT to be an effective alternative for children and adolescents with acute mental health disorders instead of hospitalization. Further evaluation with random group allocation and long-term follow-up should attempt to replicate and extend the current findings.
家庭治疗(HT)可能为患有急性精神障碍的儿童和青少年提供一种有效且具有成本效益的替代住院治疗的方法。本研究介绍并评估了瑞士伯尔尼的一个 HT 试点项目,该项目完全用 HT 替代住院治疗。共有 n=133 名患有急性精神障碍且需要住院治疗的儿童和青少年接受了新的 HT 项目(n=37)或作为常规住院治疗(I-TAU,n=96)的活跃对照组的治疗。在入院时和出院时,通过健康国家结果量表儿童和青少年临床医生评定(HoNOSCA)和自我评定(HoNOSCA-SR)评估心理病理负担。使用增强逆概率加权来评估和比较治疗效果,以调整基线差异并控制治疗持续时间。参与者年龄在 6 至 17 岁之间(M=13.71 岁,SD=2.93),其中 54%为女性。HT 使 HoNOSCA(d=0.79,p<.001)和 HoNOSCA-SR(d=0.63,p=.006)显著改善。在 HoNOSCA(d=0.01,p=.96)或 HoNOSCA-SR(d=0.11,p=.63)方面,HT 与参考组 I-TAU 之间未观察到治疗效果的显著差异。总体而言,结果表明 HT 是患有急性心理健康障碍的儿童和青少年的一种有效的替代住院治疗的方法。进一步的评估应该采用随机分组和长期随访,以尝试复制和扩展当前的发现。
Eur Child Adolesc Psychiatry. 2023-4
BMC Psychiatry. 2019-12-19
Psychiatr Danub. 2015-9
Aust N Z J Psychiatry. 2005-3
Eur Child Adolesc Psychiatry. 2025-3-10
Eur Child Adolesc Psychiatry. 2024-5
Child Adolesc Ment Health. 2016-2
Child Adolesc Ment Health. 2018-2
Z Kinder Jugendpsychiatr Psychother. 2020-9
BMC Psychiatry. 2019-12-19
J Abnorm Child Psychol. 2020-1